TY - JOUR
KW - Child
KW - Humans
KW - Adolescent
KW - *Proton Pump Inhibitors/therapeutic use
KW - Histamine
KW - Retrospective Studies
KW - *Gastroesophageal Reflux/drug therapy/epidemiology
KW - Histamine H2 Antagonists/therapeutic use
KW - United Kingdom/epidemiology
KW - Children
KW - cohort
KW - prescriptions proton pump inhibitors
KW - reflux
AU - R. Masarwa
AU - P. Reynier
AU - C. Lefebvre
AU - R. Platt
AU - J. Delaney
AU - K. Filion
AD - Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada.
Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada.
Department of Pediatrics, Centre Hospitalier Universitaire Ste-Justine, University of Montreal, Montreal, Quebec, Canada.
Department of Pediatrics, McGill University, Montreal, Quebec, Canada.
General Internal Medicine, University of Washington, Seattle, Washington, USA.
Department of Medicine, McGill University, Montreal, Quebec, Canada.
AN - 38362652
BT - Pharmacoepidemiol Drug Saf
DO - 10.1002/pds.5752
DP - NLM
ET - 2024/02/16
LA - eng
M1 - 2
N1 - 1099-1557
Masarwa, Reem
Orcid: 0000-0003-3949-3909
Reynier, Pauline
Lefebvre, Claire
Platt, Robert W
Orcid: 0000-0002-5981-8443
Delaney, Joseph A C
Orcid: 0000-0003-1771-1776
Filion, Kristian B
Orcid: 0000-0001-6055-0088
Journal Article
England
Pharmacoepidemiol Drug Saf. 2024 Feb;33(2):e5752. doi: 10.1002/pds.5752.
PY - 2024
SN - 1053-8569
EP - e5752
T2 - Pharmacoepidemiol Drug Saf
TI - Prescribing trends of proton pump inhibitors and histamine blockers among children in the United Kingdom (1998-2019): A population-based assessment
VL - 33
ER -